Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001274644-16-000092)

Filing Details

Accession Number:: 0001274644-16-000092
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-01-19 08:14:06
Reporting Period:: 2016-01-15

Filing Date:: 2016-01-19
Accepted Time:: 2016-01-19 08:14:06
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1274644	Ocera Therapeutics Inc.	OCRX	Pharmaceutical Preparations (2834)	631192270

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1551965	Gaurav Aggarwal	C/O Ocera Therapeutics, Inc. 525 University Avenue, Suite 610 Palo Alto CA 94301	Chief Business Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-01-15	10,000	$2.15	20,000	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Footnotes

Represents the weighted average price for the shares. The shares were purchased at prices ranging from $2.11 per share to $2.21 per share.
The reporting person will provide to the Securities and Exchange Commission staff, the issuer, or any security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.